skip to main content

    Updated Visitor Guidelines

 

MENU

 

Pancreatic Cancer

Why Every Pancreatic Cancer Patient Should Consider Genetic Testing

It now appears that as many as 1 in 10 patients diagnosed with pancreatic cancer carry a genetic alteration associated with an increased risk of pancreatic or other cancer types. If family members learn they may be at risk for pancreatic or other cancer types, they have more opportunities to take action.

Treatment Targets Tough Cancers by Bathing Tumors in Chemo

The biggest threat cancer poses happens when it spreads throughout the body -- and when it has spread to the lining of the abdominal cavity it's particularly tricky. Once these advanced cancers have entered that area, they’re notoriously difficult to treat. Surgery alone is rarely successful, and traditional chemotherapy yields limited results, but a treatment called HIPEC offers hope.

The Act of Sharing

Four years after being diagnosed with stage 4 pancreatic cancer, Rose Mary Worthen faces every day with hope. Her passion for art led her to create inspirational charms -- or stones -- that she shares with others. Sharing hope, sharing joy, sharing laughter keeps her going.

Starving Pancreatic Cancer by Targeting Cell Metabolism

Media contact: Nicole Fawcett, 734-764-2220 | Patients may contact Cancer AnswerLine™, 800-865-1125
microscopic view of pancreatic cancer cells

Comprehending how pancreatic tumor cells thrive might be the key to new therapies and diagnostic tools.

The biochemical pathways and metabolic requirements that enable tumor survival and growth may be used to design targeted cancer therapies.

What makes pancreatic cancer tumors grow?

Media contact: Nicole Fawcett, 734-764-2220 | Patients may contact Cancer AnswerLine™, 800-865-1125
graphic of a pancreas

A metabolic cross-talk pathway between cancer and noncancer cells in pancreatic tumors delivers an alternative nutrient to the cancer cells, facilitating tumor growth.

Study challenges potential pancreatic cancer target

A protein thought to fuel pancreatic cancer development plays a much more complicated role, a new study finds. PDX1 is critical for cancer growth, but blocking it may lead to more aggressive tumors.

University of Michigan joins national effort to transform outcomes for pancreatic cancer patients

The University of Michigan Rogel Cancer Center is one of 12 sites to join Precision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer.

Pages